Table 3 Distribution of QoL scores by stage of disease and prior treatment history
From: Quality of life assessment as a predictor of survival in non-small cell lung cancer
QLQ-C30 Scale | Stage of disease | Treatment History | ||||
|---|---|---|---|---|---|---|
| Â | Locoregional (N = 511) | Metastatic (N = 656) | P | Newly diagnosed (N = 605) | Previously treated (N = 589) | P |
Global | 53.8 | 53.1 | 0.63 | 56.1 | 50.8 | 0.001 |
Physical | 69.4 | 68.0 | 0.35 | 73.1 | 64.1 | < 0.001 |
Role | 60.4 | 57.2 | 0.12 | 62.4 | 55.2 | < 0.001 |
Emotional | 64.5 | 63.5 | 0.55 | 63.3 | 64.8 | 0.33 |
Cognitive | 75.1 | 74.5 | 0.68 | 75.9 | 73.7 | 0.16 |
Social | 62.0 | 60.2 | 0.35 | 65.3 | 56.8 | < 0.001 |
Fatigue | 45.0 | 48.6 | 0.03 | 43.1 | 50.6 | < 0.001 |
Nausea/Vomiting | 13.9 | 15.1 | 0.36 | 12.2 | 16.8 | < 0.001 |
Pain | 34.7 | 39.0 | 0.02 | 34.0 | 40.3 | 0.001 |
Dyspnea | 39.5 | 36.0 | 0.08 | 34.7 | 40.6 | 0.002 |
Insomnia | 39.0 | 41.0 | 0.31 | 40.5 | 39.3 | 0.54 |
Appetite Loss | 30.2 | 32.3 | 0.29 | 28.4 | 34.1 | 0.004 |
Constipation | 22.7 | 25.4 | 0.14 | 23.2 | 25.2 | 0.27 |
Diarrhea | 9.9 | 9.8 | 0.92 | 8.8 | 10.9 | 0.07 |